A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 33/24 (2006.01) A61K 31/7068 (2006.01) A61P 35/00 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2719202
Provision of a novel combined therapy with ECyd, which therapy exhibits remarkable antitumor effect and gives less adverse effects. The invention provides an antitumor agent containing, in combination, 1-(3-C-ethynyl-.beta.-D-ribopentofuranosyl)cytosine or a salt thereof and carboplatin.
La présente invention concerne une nouvelle polythérapie utilisant Ecyd, qui a un effet antitumoral remarquable et a peu d'effets secondaires indésirables. L'invention concerne en particulier un agent antitumoral comprenant une combinaison de 1-(3-C-éthynyl-ß-D-ribopentofuranosyl)-cytosine ou un sel de celle-ci et de la carboplatine.
Matsuda Akira
Sasaki Takuma
Smart & Biggar
Taiho Pharmaceutical Co. Ltd.
LandOfFree
Anti-tumor agent comprising cytidine derivative and carboplatin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-tumor agent comprising cytidine derivative and carboplatin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-tumor agent comprising cytidine derivative and carboplatin will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2086337